House Dust Mite Allergy Drugs Market Insights Video
According to Cognitive Market Research, the global house dust mite allergy drug market size was USD 1834.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 14.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 733.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 550.35 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 421.94 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 91.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 36.69 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2031.
The hospitals pharmacy category is the fastest growing segment of the house dust mite allergy drug industry
